Pfizer Inc (PFE)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$23.30

Buy

$23.31

arrow-down$-0.43 (-1.82%)

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
Prices updated at 29 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.56%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Dr. Albert Bourla, D.V.M.,PhD
CEO
Dr. Albert Bourla, D.V.M.,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
81,000
Head office
66 Hudson Boulevard East
New York
United States
10001-2192
mobile
+1 212 733-2323
letter
IR@pfizer.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. David M. Denton
Chief Financial Officer and Executive Vice President
1.35m--8.12m-
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
-----
Ms. Sally Susman
Chief Corporate Affairs Officer and Executive Vice President
-----
Mr. Ronald E. Blaylock
Independent Director
0.16m--0.36m-
Mr. Shantanu Narayen
Lead Independent Director
0.21m--0.45m-
Ms. Suzanne Nora Johnson
Independent Director
0.19m--0.41m-
Dr. Scott Gottlieb,M.D.
Independent Director
0.19m--0.39m-
Mr. James Robert Quincey
Independent Director
0.16m--0.38m-
Dr. Susan J. Hockfield, PhD
Independent Director
0.16m--0.36m-
Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
Independent Director
0.16m--0.36m-
Mr. Douglas M. Lankler
Chief Legal Officer and Executive Vice President
-----
Mr. James C. Smith
Independent Director
0.19m--0.39m-
Dr. Albert Bourla, D.V.M.,PhD
Chairman of the Board and Chief Executive Officer
1.80m--24.65m-
Mr. Joseph J. Echevarria
Independent Director
0.19m--0.39m-
Ms. Margaret M. Madden
Senior Vice President, Corporate Secretary and Chief Governance Counsel
-----
Mr. Cyrus Taraporevala
Independent Director
0.08m--0.27m-
Dr. Dan R. Littman, M.D.,PhD
Independent Director
0.16m--0.38m-
Ms. Jennifer B. Damico
Principal Accounting Officer, Senior Vice President and Controller
-----
Ms. Payal Sahni
Chief People Experience Officer and Executive Vice President
-----
Mr. Aamir Malik
Chief U.S. Commercial Officer and Executive Vice President
1.34m--8.29m-
Mr. Michael McDermott
Executive Vice President, Chief Global Supply and Quality Officer
-----
Dr. Chris Boshoff, M.D.,PhD
Chief Scientific Officer and President, Research and Development
1.20m--7.85m-
Mr. Alexandre de Germay
Chief International Commercial Officer and Executive Vice President
-----
Dr. Andrew Baum, M.D.
Executive Vice President, Chief Strategy and Innovation Officer
-----
Mr. Mortimer J. Buckley
Independent Director
0.03m--0.15m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc523,165,1270.2396846299760.89289530 Apr 20259.20
BlackRock Inc474,167,5920.25237224275414.96470130 Apr 20258.34
State Street Corp296,970,5280.310164861782.23288430 Apr 20255.22
Vanguard Investments Australia Ltd182,559,0492.87845184764-30 Apr 20253.21
Vanguard Total Stock Market Index Fund181,790,2160.2582326634841.48692730 Apr 20253.20

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Mr. Shantanu Narayen26.5349,983154,711--
31 Dec 2024-Mr. James Robert Quincey26.5338,73455,029--
31 Dec 2024-Mr. James C. Smith26.5344,995139,544--
31 Dec 2024-Mr. Rady A. Johnson26.531869,379--
31 Dec 2024-Dr. Albert Bourla, D.V.M.,PhD26.53531690,585--
31 Dec 2024-Mr. Joseph J. Echevarria26.5346,242123,639--
31 Dec 2024-Mr. Cyrus Taraporevala26.5337,4879,084--
13 Dec 2024-Mr. Rady A. Johnson25.581799,373--
13 Dec 2024-Dr. Albert Bourla, D.V.M.,PhD25.58537690,626--
29 Nov 2024-Mr. Rady A. Johnson26.211839,363--
29 Nov 2024-Dr. Albert Bourla, D.V.M.,PhD26.21524690,388--
15 Nov 2024-Mr. Rady A. Johnson24.801989,365--
15 Nov 2024-Dr. Albert Bourla, D.V.M.,PhD24.80521691,116--
31 Oct 2024-Mr. Rady A. Johnson28.301989,197--
31 Oct 2024-Dr. Albert Bourla, D.V.M.,PhD28.30538679,129--
30 Oct 2024-Dr. Scott Gottlieb,M.D.28.2428,24010,000--
15 Oct 2024-Mr. Rady A. Johnson29.441779,189--
15 Oct 2024-Dr. Albert Bourla, D.V.M.,PhD29.44530679,044--
10 Oct 2024-Mr. Rady A. Johnson29.348519,183--
10 Oct 2024-Dr. Albert Bourla, D.V.M.,PhD29.342,024679,059--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.